Literature DB >> 12050175

Immune escape of tumors: apoptosis resistance and tumor counterattack.

Frederik H Igney1, Peter H Krammer.   

Abstract

Interactions between the immune system and malignant cells play an important role in tumorigenesis. Failure of the immune system to detect and reject transformed cells may lead to cancer development. Tumors use multiple mechanisms to escape from immune-mediated rejection. Many of these mechanisms are now known on a cellular and molecular level. Despite this knowledge, cancer immunotherapy is still not an established treatment in the clinic. This review discusses the immune escape mechanisms used by tumors with an emphasis on mechanisms related to apoptosis.

Entities:  

Mesh：

Year:  2002        PMID： 12050175

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


  131 in total

Review 1.  Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy.

Authors:  Arvind Chhabra
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

2.  Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors:  Eiman Adel Hasby
Journal:  Pathol Oncol Res       Date:  2011-12-08       Impact factor: 3.201

3.  Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.

Authors:  Samaneh Boroumand-Noughabi; Hamid Reza Sima; Kamran Ghaffarzadehgan; Mostafa Jafarzadeh; Hamid Reza Raziee; Hanieh Hosseinnezhad; Omeed Moaven; Mohammad Taghi Rajabi-Mashhadi; Amir Abbas Azarian; Mojtaba Mashhadinejad; Jalil Tavakkol-Afshari
Journal:  BMC Cancer       Date:  2010-06-10       Impact factor: 4.430

Review 4.  Lung cancer vaccines.

Authors:  Ronan J Kelly; Giuseppe Giaccone
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

5.  PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.

Authors:  David C Qian; Xiangjun Xiao; Jinyoung Byun; Arief A Suriawinata; Stephanie C Her; Christopher I Amos; Richard J Barth
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

6.  Modifying Dendritic Cell Activation with Plasmonic Nano Vectors.

Authors:  Kieng Bao Vang; Ingrid Safina; Emilie Darrigues; Dmitry Nedosekin; Zeid A Nima; Waqar Majeed; Fumiya Watanabe; Ganesh Kannarpady; Rajshekhar A Kore; Daniel Casciano; Vladimir P Zharov; Robert J Griffin; Ruud P M Dings; Alexandru S Biris
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

7.  MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model.

Authors:  Sang-Yeul Lee; Jeong-Im Sin
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis.

Authors:  Vladimir N Ivanov; Ze'ev Ronai; Tom K Hei
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

Review 9.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

10.  Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

Authors:  Céline A Blache; Edwin R Manuel; Teodora I Kaltcheva; Andrea N Wong; Joshua D I Ellenhorn; Bruce R Blazar; Don J Diamond
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.